Detalhe da pesquisa
1.
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar.
J Antimicrob Chemother
; 74(12): 3497-3504, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504587
2.
Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar.
Antibiotics (Basel)
; 13(4)2024 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666996
3.
The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019.
JAC Antimicrob Resist
; 5(4): dlad086, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546546
4.
Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 ß-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa.
Antibiotics (Basel)
; 11(2)2022 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203733
5.
Evaluation of in Vitro Activity of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against ESBL-producing Enterobacterales Isolated from Intensive Care Units from Qatar.
Oman Med J
; 37(5): e422, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36188876
6.
Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar.
Antimicrob Steward Healthc Epidemiol
; 2(1): e96, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483382
7.
Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar.
Ann Med
; 53(1): 2345-2353, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882052
8.
ß-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar.
Antimicrob Resist Infect Control
; 9(1): 170, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131487
9.
Impact of an antimicrobial stewardship programme on antimicrobial utilization and the prevalence of MDR Pseudomonas aeruginosa in an acute care hospital in Qatar.
JAC Antimicrob Resist
; 2(3): dlaa050, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223010
10.
The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics.
Lung India
; 34(6): 527-531, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29098998
11.
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis.
Infect Drug Resist
; 8: 83-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25995646